| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4a20a55ac730756ddd3ce7525bf2179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-12-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1860615f57540fc9b92f843394e67293 |
| publicationDate |
2005-06-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005055933-A2 |
| titleOfInvention |
Treatment of psoriasis with rosiglitazone |
| abstract |
There is provided a method of treatment of psoriasis which comprises administering to a patient in need thereof by the oral route a pharmaceutical composition comprising rosiglitazone, or a pharmaceutically acceptable salt or solvate thereof, together with a pharmaceutically acceptable carrier, wherein the method comprises administering 2 to 8 mg rosiglitazone per day. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504679-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10426763-B2 |
| priorityDate |
2003-12-03^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |